Balyasny Asset Management’s BioCryst Pharmaceuticals BCRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q4 | – | Sell |
|
|||||
|
2025
Q3 | $661K | Sell |
|
|||||
|
2025
Q2 | $2.26M | Sell |
|
|||||
|
2025
Q1 | $4.4M | Buy |
|
|||||
|
2024
Q4 | $3.98M | Buy |
|
|||||
|
2024
Q1 | – | Sell |
|
|||||
|
2023
Q4 | $11.8M | Buy |
|
|||||
|
2023
Q3 | $2.89M | Buy |
|
|||||
|
2022
Q4 | – | Sell |
|
|||||
|
2022
Q3 | $15.4M | Buy |
|
|||||
|
2022
Q2 | $12.6M | Buy |
|
|||||
|
2020
Q2 | – | Sell |
|
|||||
|
2020
Q1 | $6.01M | Buy |
|
|||||
|
2018
Q1 | – | Sell |
|
|||||
|
2017
Q4 | $54K | Sell |
|
|||||
|
2017
Q3 | $282K | Buy |
|
|||||
|
2015
Q3 | – | Sell |
|
|||||
|
2015
Q2 | $1.3M | Buy |
|